Endologix (NASDAQ: ELGX) reported Q2 EPS revenue of $36.2 million versus the consensus estimate of $36.01 million.“We are pleased with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE